返回期刊详情

Oncogenesis

IF6.4

论文数1030

被引数4427

期刊论文 1030

发表时间

Co-targeting ASAH1 and the histone reader BRD1 potently suppresses TNBC growth through the transcriptional repressor BCL6 联合靶向ASAH1和组蛋白读取蛋白BRD1通过转录抑制因子BCL6显著抑制三阴性乳腺癌生长

Oncogenesis

IF6.4

2026-10-24

OAAI

Siva Chander Chabattula; Patrick T. Ball; Alok Kartha; Kiran Kumar Reddi; Yvonne J. K. Edwards; Romi Gupta

Metabolic and epigenetic reprogramming as novel vulnerabilities in renal cell carcinoma 代谢和表观遗传重编程作为肾细胞癌的新型易损性

Oncogenesis

IF6.4

2026-10-24

OAAI

Angela Cappello; Giuseppina Leuzzi; Lavinia Ferrone; Laura Cosmai; Sara Di Bari; Luciano Mutti; Camillo Porta; Carlo Ganini

Macrophage-mediated extracellular matrix remodeling awakens dormant breast cancer cells 巨噬细胞介导的细胞外基质重塑唤醒休眠的乳腺癌细胞

Oncogenesis

IF6.4

2026-10-23

OAAI

Kitti Jenovai; Pascal Lopez; Enora Lecorgne; Isabelle Bourget; Alexandra Mousset; Lola Bellone; Milena Bellon; Florian Tuffin; Stoyan Ivanov; Giulia Chinetti; Jean Albrengues; Cedric Gaggioli

Meeting Report of the 6th edition of metabolism and cancer symposium 第六届代谢与癌症研讨会的会议报告

Oncogenesis

IF6.4

2026-10-22

OAAI

Ana Carolina B. Sant’Anna-Silva; Chloe Del Bove; Georgios Efthymiou; Emma Henry; Laura Henry; Jigna Kundnani; Rodrigue Rossignol; Sophie Zimmermann

SMPD3 enhances MHC-I surface presentation to drive CD8⁺ T-cell immunity in colorectal cancer SMPD3增强MHC-I表面呈递以驱动结直肠癌中CD8⁺ T细胞免疫

Oncogenesis

IF6.4

2026-10-22

OAAI

Bin Tan; Longzhu Zhong; Wentao Zeng; Nuozhou Weng; Jiayu Gu; Lianji Weng; Huilin Wen; Haocheng Xiao; Dandan Jin; Kehong Zheng

Correction: NRF2 signaling plays an essential role in cancer progression through the NRF2-GPX2-NOTCH3 axis in head and neck squamous cell carcinoma 更正：NRF2信号通路通过NRF2-GPX2-NOTCH3轴在头颈部鳞状细胞癌进展中发挥关键作用

Oncogenesis

IF6.4

2026-10-19

OAAI

Xiaoye Jin; Xiayuan Lou; Haoxiang Qi; Chao Zheng; Bo Li; Xuerong Siwu; Ren Liu; Qiaoli Lv; An Zhao; Jian Ruan; Ming Jiang

ABE-mediated dual targeting of TOX and ARHGEF1 synergistically enhances antitumor activity of tumor-infiltrating lymphocytes in PDAC ABE介导的TOX和ARHGEF1双重靶向协同增强肿瘤浸润淋巴细胞在PDAC中的抗肿瘤活性

Oncogenesis

IF6.4

2026-10-13

OAAI

Xi Ma; Huihui Sun; Kejia Liu; Haorui Li; Yu Guo; Xugang Sun; Xiang He; Yibo Dou; Henan Cao; Chao Yang; Tiansuo Zhao

AP2M1 promotes TNBC progression by stabilizing EGFR through inhibition of lysosomal degradation AP2M1通过抑制溶酶体降解稳定EGFR促进TNBC进展

Oncogenesis

IF6.4

2026-10-11

OAAI

Xiongyizhou Zhao; Haiyu Wang; Yihong Luo; Zheng Gong; You Zhu; Chuxun Wu; Jingyi Wang; Yufan Cai; Junxian Du; Lei Shen; Wei Zhu

Histone H3K18 lactylation fuels MTHFD2-driven SAM biosynthesis to promote SPINT2 promoter hypermethylation and ovarian cancer progression 组蛋白H3K18乳酰化驱动MTHFD2介导的SAM生物合成，促进SPINT2启动子超甲基化及卵巢癌进展

Oncogenesis

IF6.4

2026-10-09

OAAI

Yusen Liang; Yimei Meng; Xiaoyan Ma; Jingmeng Wang; Peiling Li

Dynamic plasticity of cancer-associated fibroblasts during tumor progression: emerging concepts 肿瘤进展过程中癌相关成纤维细胞的动态塑性：新兴概念

Oncogenesis

IF6.4

2026-10-01

OAAI

Chloé C. Lefebvre; Philippe P. Juin; Frédérique Souazé

Metabolic and DNA-based assays provide equally reliable measures of cell viability across experimental conditions 代谢和DNA基 assays 提供了跨实验条件的细胞活力同等可靠的测量方法

Oncogenesis

IF6.4

2026-09-28

OAAI

Inès C. N. Avenel; Hanneke W. M. van Laarhoven; Maarten F. Bijlsma

Estrogen stimulation induces centrosome amplification through estrogen receptor alpha-mediated DNA damage 雌激素刺激通过雌激素受体α介导的DNA损伤诱导中心体扩增

Oncogenesis

IF6.4

2026-09-25

OAAI

Yuki Yoshino; Shiori Ichimura; Natsuko Chiba

Deacetylation-dependent stabilization of VASH2 drives YAP activation leading to colorectal cancer progression and chemoresistance 去乙酰化依赖性稳定VASH2驱动YAP激活，从而导致结直肠癌进展和化疗耐药性

Oncogenesis

IF6.4

2026-09-24

OAAI

Jie Shen; Baopeng Tian; Shuo Gong; Ge Mo; Zhen Luo; Yuhong Zhou; Chun Dai; Jie Dou; Min Guo

Catechol-O-methyltransferase bioactivation of the imiqualine EAPB02303 generates EAPB04303, a broadly active anti-leukemic agent in acute myeloid leukemia 儿茶酚-O-甲基转移酶生物活化咪喹啉EAPB02303生成EAPB04303，一种在急性髓系白血病中广泛活性的抗白血病药物

Oncogenesis

IF6.4

2026-09-22

OAAI

Perla Makhoul; Rita Hleihel; Maya AbdelKhalek; Abdullah El-Kurdi; Mohamed Hamed; Stéphanie Paniagua-Gayraud; Cindy Patinote; Marwan El Sabban; Carine Deleuze-Masquefa; Pierre-Antoine Bonnet; Hiba El Hajj

Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression 丙烯醛-硫氧还蛋白1-p38信号通路驱动中性粒细胞介导的免疫抑制和胶质母细胞瘤进展

Oncogenesis

IF6.4

2026-09-14

OAAI

Zhen-Jie Tong; Tsong-Long Hwang; Kuo-Chen Wei; Chiung-Yin Huang; Pin-Yuan Chen; Ko-Ting Chen; Ya-Jui Lin; Hong-Chieh Tsai; Hsiang-Tsui Wang

Compartmentalisation of death receptor signalling in cancer 癌症中死亡受体信号的区室化

Oncogenesis

IF6.4

2026-08-31

OAAI

Victoria Maltret; Elodie Lafont

NKCC1 as a regulator of stemness and redox balance in colorectal cancer NKCC1作为结直肠癌干性及氧化还原平衡的调控因子

Oncogenesis

IF6.4

2026-08-31

OAAI

Pierre Adam; Catherine Salée; Pauline Bomboire; Marty Stepniak; Arnaud Lavergne; Charlotte Massot; Carla Coimbra Marques; Emmanuel Decker; Benjamin Koopmansch; Frederic Lambert; Philippe Delvenne; Edouard Louis; Marie-Alice Meuwis

Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis 骨桥蛋白1通过NOTCH1/STAT3/GFPT2轴参与胶质瘤干细胞表型可塑性

Oncogenesis

IF6.4

2026-08-29

OAAI

Feng Tian; Kangming Zhu; Yanfei Sun; Shuhua Guo; Xing Guo; Chuanxin Wang; Shuo Xu

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11 CD44v5通过增强IL-4/IL-4Rα/STAT3通路并稳定膜SLC7A11促进三阴性乳腺癌顺铂耐药

Oncogenesis

IF6.4

2026-08-21

OAAI

Lan Wang; Xinyi Bao; Hongyun Ma; Zhongjian Ji; Jiaren Liu; Meng Jiang; Yanhua Dai; Nan Li; Chun Yang

A novel combinatorial treatment for Neurofibromatosis type 1 tumours revealed through cross-species genetic analysis 通过跨物种遗传分析揭示的神经纤维瘤病1型肿瘤的一种新型组合疗法

Oncogenesis

IF6.4

2026-08-21

OAAI

Megan Stevens; Sebastian Oltean; Benjamin E. Housden